Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 5, 2001 - Issue 6
Submit an article Journal homepage
18
Views
4
CrossRef citations to date
0
Altmetric
Miscellaneous

Metabotropic glutamate receptors: targets for therapy of cerebral ischaemia

Gabriele Costantino Dipartimento di Chimica e Tecnologia del Farmaco,Università di Perugia,Via del Liceo, 1.06123- Perugia, Italy, E-mail:[email protected]
,
Roberto Pellicciari Dipartimento di Chimica e Tecnologia del Farmaco,Università di Perugia,Via del Liceo, 1.06123- Perugia, Italy, E-mail:[email protected]
&
Antonio Macchiarulo Dipartimento di Chimica e Tecnologia del Farmaco,Università di Perugia,Via del Liceo, 1.06123- Perugia, Italy, E-mail:[email protected]
Pages 669-683 | Published online: 25 Feb 2005

Bibliography

  • GOLDSTEIN LB: Medical therapy for acute ischemic stroke. Carr: Atherosclec Rep. (2001) 3:299–306.
  • DIRNAGL H, IADECOLA C, MOSKOWITZ MA: Pathobiology of ischemic stroke: an integrated view. Trends Neurosci (1999) 22:391–397.
  • WHITE BC, SULLIVAN JM, DEGRACIA DJ et al.: Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. Neurol Sci (2000) 179(S1-2):1–33.
  • NEUMAR RW: Molecular mechanisms of ischemic neuronal injury. Ann. Emerg. Med. (2000) 36:483–506.
  • CONN PJ, PIN JP: Pharmacology and functions of metabotropic glutamate receptors. Anna. Rev Pharmacol Toxicol (1997) 37:205–237.
  • BOCKAERT J, PIN JP: Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. (1999) 18:1723–1729.
  • PARMENTIER ML, PIN JP, BOCKAERTJ, GRAU Y: Cloning and functional expression of a Drosophila metabotropic glutamate receptor expressed in the embryonic CNS. Neurosci. (1996) 16:6687–6694.
  • ALBANI-TORREGROSSA S, ATTUCCI S, MARINOZZI M, PELLICCIARI R, MORONI F, PELLEGRINI-GIAMPIETRO DE: Antagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R,1'S,2'R,3'S)-2-(2'-carboxy-3'-phenylcyclopropyflglycine versus 2,3-dihydroxyphenylglycine. Mol. Pharmacol (1999) 55:699–707.
  • BOSS VK, CONN PJ: Metabotropic excitatory amino acid receptor activation stimulates phospholipase D in hippocampal slices. Neurochem. (1992) 59:2340–2343.
  • BOSS VK, NUTT M, CONN PJ: L-cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to phospholipase D activity. Ma Phannacol (1994) 45:1177–1182.
  • MASU M, TANABE Y, TSUCHIDA K, SHIGEMOTO R, NAKANISHI S: Sequence and expression of a metabotropic glutamate receptor. Nature (1991) 349:760–765.
  • NAKANISHI S: Molecular diversity of glutamate receptors and implications for brain function. Science (1992) 258:597–603.
  • ROMANO C, YANG WL, O'MALLEY K:Metabotropic glutamate receptor 5 is a disulfide-linked dimer. I Biol. Chem. (1996) 271:28612–28616.
  • O'HARA PJ, SHEPPARD PO, THOGERSEN H et al: The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron (1993) 11:41–52.
  • TAKAHASHI K, TSUCHIDA K, TANABE Y, MASU M, NAKANISHI S: Role of the large extracellular domain of metabotropic glutamate receptors in agonist selectivity determination. J. Biol. Chem. (1993) 268:19341–19345.
  • SHIGEMOTO R, ABET, NOMURA S, NAKANISHI S, HIRANO T: Antibodies inactivating mGluR1 metabotropic glutamate receptor block long-term depression in cultured Purkinje cells. Neuron (1994) 12:1245–1255.
  • OKAMOTO T, SEKIYAMA N, OTSU M et al.: Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. J. Biol. Chem. (1998) 273:13089–13096.
  • MAO B, PEAR MR, MCCAMMON JA, QUIOCHO FA: Hinge-bending in L-arabinose-binding protein. The "Venus's-flytrap" model. J. Biol. Chem. (1982) 257:1131–1133.
  • GALVEZ T, PARMENTIER ML, JOLY Cet al.: Mutagenesis and modeling of the GABAB receptor extracellular domain support a venus flytrap mechanism for ligand binding. J. Biol. Chem. (1999) 274:13362–13369.
  • COSTANTINO G, PELLICCIARI R: Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists. J. Med. Chem (1996) 39:3998–4006.
  • COSTANTINO G, MACCHIARULO A, PELLICCIARI R: Modeling of amino-terminal domains of group I metabotropic glutamate receptors: structural motifs affecting ligand selectivity. Med. Chem (1999) 42:5390–5401.
  • COSTANTINO G, MACCHIARULO A, PELLICCIARI R: Homology model of the closed, functionally active, form of the amino terminal domain of mGluRl. Bioorg. Med. Chem. (2001) 9:847–852.
  • BESSIS AS, BERTRAND HO, GALVEZ T, DE COLLE C, PIN JP, ACHER F: Three-dimensional model of the extracellular domain of the type 4a metabotropic glutamate receptor: new insights into the activation process. Protein Sci (2000) 9:2200–2209.
  • JENSEN AA, SHEPPARD PO, O'HARA PJ, KROGSGAARD-LARSEN P, BRAUNER-OSBORNE H: The role of Arg(78) in the metabotropic glutamate receptor mG1u(1) for agonist binding and selectivity. Eur: J Pharmacol (2000) 397:247–253.
  • HAMPSON R, HUANG XP, PEKHLETSKI et al: Probing the ligand-binding domain of the mGluR4 subtype of metabotropic glutamate receptor. J. Biol. Chem. (1999) 274:33488–33495.
  • COSTANTINO G, NATALINI B, PELLICCIARI R, MORONI F, LOMBARDI G: Definition of a pharmacophore for the metabotropic glutamate receptors negatively linked to adenylyl cyclase. Bioorg. Med. Chem. (1993) 1:259–265.
  • COSTANTINO G, MACCHIARULO A, PELLICCIARI R: Pharmacophore models of group I and group II metabotropic glutamate receptor agonists. Analysis of conformational, steric, and topological parameters affecting potency and selectivity. J. Med. Chem. (1999) 42:2816–2827.
  • JULLIAN N, BRABET I, PIN F, ACHER FC: Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation. J. Med. Chem. (1999) 42:1546–1555.
  • BESSIS AS, JULLIAN N, COUDERT E,PIN JP, ACHER F: Extended glutamate activates metabotropic receptor types 1, 2 and 4: selective features at mGluR4 binding site. Neuropharmacology (1999) 38:1543–1551.
  • KUNISHIMA N, SHIMADA Y, TSUJI Y et al: Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (2000) 407:971–977.
  • ROMANO C, MILLER JK, HYRC K et al.: Covalent and noncovalent interactions mediate metabotropic glutamate receptor mG1u5 dimerization. MM. Pharmacoi (2001) 59:46–53.
  • DE BLASI A, CONN PJ, PIN J, NICOLETTI F: Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci (2001) 22:114–120.
  • ANGO F, PREZEAU L, MULLER T et al: Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein homer. Nature (2001) 411:962–965.
  • CHOI DW: Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. (1995) 18:58–60.
  • LUTSEP HL, CLARK WM: Neuroprotection in acute ischaemic stroke. Current status and future potential. Drugs R &D. (1999) 1:3–8.
  • NICOLETTI F, BRUNO V, COPANI A,CASABONA G, KNOPFEL T: Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci. (1996) 19:267–271.
  • BRUNO V, BATTAGLIA G, KINGSTON A et al.: Neuroprotective activity of the potent and selective mGlul a metabotropic glutamate receptor antagonist, (+)-2-methy1-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlul a and mG1u5 receptors. Neuropharmacology(1999) 38:199–207.
  • FERRAGUTI F, PIETRA C, VALERIO E, CORTI C, CHIAMULERA C, CONQUET F: Evidence against a permissive role of the metabotropic glutamate receptor 1 in acute excitotoxicity. Neuroscience (1997) 79:1–5.
  • PIZZI M, BORONI F, BIANCHETTI KM, MEMO M, SPANO P: Reversal of glutamate excitotoxicity by activation of PKC-associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression. Eut: I Neurosci. (1999) 11:2489–2496.
  • CHAVIS P, FAGNI L, LANSMAN JB, BOCKAERT J: Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature (1996) 382:719–722.
  • STRASSER U, LOBNER D, BEHRENS MM, CANZONIERO LM, CHOI DW: Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures. Eut: Neurosci (1998) 10:2848–2855.
  • MORISHITA W, KIROV SA, ALGER BE: Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA 1. I Neurosci (1998) 18:4870–4882.
  • BRUNO V, BATTAGLIA G, COPANI A etal.: An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors. Eut: Neurosci. (2001) 13:1469–1478.
  • EATON SA, JANE DE, JONES PL et al:Competitive antagonism at metabotropic glutamate receptors by (S)-4-carboxyphenylglycine and (RS)-alpha-methy1-4-carboxyphenylglycine. Eut: Pharmacol (1993) 244:195–197.
  • PELLICCIARI R, LUNEIA R, COSTANTINO G et al.: 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors. Med. Chem. (1995) 38:3717–3719.
  • PELLICCIARI R, RAIMONDO M, MARINOZZI M, NATALINI B, COSTANTINO G, THOMSEN C: (5)-(-0-2- (3'-carboxybicyclo [1.1.11penty1)-glycine, a structurally new group I metabotropic glutamate receptor antagonist. Med. Chem. (1996) 39:2874–2876.
  • CLARK BP, BAKER SR, GOLDSWOTHYJ, HARRIS JR, KINGSTON AE: (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate receptors. Bioorg. Med. Chem. Lett. (1997) 7:2777–2780.
  • DOHERTY AJ, PALMER MJ, HENLEY JM, COLLINGRIDGE GL, JANE DE: (RS)-2-chloro-5 hydroxyphenylglycine (CHPG) activates mG1u5, but no mGlul, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology (1997) 36 :265–267.
  • LITSCHIG S, GASPARINI F, RUEEGG D et al.: CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. MM. Pharmacol (1999) 55:453–461.
  • GASPARINI F, LINGENHOHL K, STOEHR N et al.: 2-Methy1-6-(phenylethyny1)-pyridine (MPEP), a potent, selective and systemically active mG1u5 receptor antagonist. Neuropharmacology (1999) 38:1493–1503.
  • VARNEY MA, COSFORD ND, JACHEC C et al: SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J. Pharmacol Exp. Ther. (1999) 290:170–181.
  • CARROLL FY, STOLLE A, BEART PM etal.: BAY36-7620: a potent non-competitive mGlul receptor antagonist with inverse agonist activity. Mot. Pharmacol (2001) 59:965–973.
  • PAGANO A, RUEGG D, LITSCHIG S et al.: The non-competitive antagonists 2-methyl-6- (phenylethynyOpyridine and 7-hydroxyimino cyc lopropa n [b] c hro m e n- 1 a - carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors. j. Biol. Chem. (2000) 275:33750–33758.
  • OTT D, FLOERSHEIM P, INDERBITZIN W et al.: Chiral resolution, pharmacological characterization, and receptor docking of the noncompetitive mGlul receptor antagonist (+1-) 2 hydroxyimino-1a, 2-dihydro-1H-7- oxacyclopropa [b] naphthalene-7a-carboxylic acid ethyl ester. Med. Chem. (2000) 43:4428–4436.
  • PELLEGRINI-GIAMPIETRO DE, COZZI A, PERUGINELLI F et al.: 1-Aminoindan-1, 5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo [1 .1.11 penty1)-glycine, two mGlul receptor-preferring antagonists, reduce neuronal death in vitro and in vivo models of cerebral ischaemia. Eur: I Neurosci. (1999) 11:3637–3647.
  • KINGSTON AE, O'NEILL MJ, BOND A et al.: Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors. Ann. NY Acad. ScL (1999) 890:438–449.
  • RAO AM, HATCHER JF, DEMPSEY RJ: Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil. NeuroscL Lett. (2000) 293:1–4
  • BATTAGLIA G, BRUNO V, PISANI A et al.: Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. MM. Cell Neurosci. (2001) 17:1071–1083.
  • ALLEN JW, VICINI S, FADEN Al: Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release. Exp. Neurol (2001) 169:449–460.
  • COZZI A, ATTUCCI S, PERUGINELLI F et al.: Type 2 metabotropic glutamate (mG1u) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,l'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a new potent and selective antagonist. Eur: NeuroscL (1997) 9:1350–1355.
  • ISHIDA M, SAITOH T, SHIMAMOTO K, OHFUNE Y, SHINOZAKI H: A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the new-born rat isolated spinal cord. ELI Pharmacol (1993) 109:1169–1177.
  • PELLICCIARI R, MARINOZZI M, NATALINI B et al: Synthesis and pharmacological characterization of all sixteen stereoisomers of 2-(2'-carboxy-3'-phenylcyclopropyl)glycine. Focus on (2S,l'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a novel and selective group II metabotropic glutamate receptors antagonist. Med. Chem. (1996) 39: 2259–2269.
  • KOZIKOWSKI AP, STEENSMA D, ARALDI GL et al: Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist. Med. Chem. (1998) 41:1641–1650.
  • MONN JA, VALLI MJ, MASSEY SM et al.: Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo [3.1.01hexane- 2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. Med. Chem. (1997) 40:528–537.
  • MONN JA, VALLI MJ, MASSEY SM et al.: Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+) -2 -aminobicyclo [3.1.01hexane- 2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. Med. Chem. (1999) 42:1027–1040.
  • ORNSTEIN PL, BLEISCH TJ, ARNOLD MB, WRIGHT RA, JOHNSON BG, SCHOEPP DD: 2-Substituted (2512)-2-amino-2-((1SR,25R)-2-carboxycycloprop-1-yOglycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution. Med. Chem. (1998) 41:346–357.
  • WROBLEWSKA B, WROBLEWSKI JT, SAAB OH, NEALE JH: N-acetylaspartylglutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells. Neurochem. (1993) 61:943–948.
  • BOND A, O'NEILL MJ, HICKS CA, MONN JA, LODGE D: Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport (1998) 9:1191–1193.
  • LAM AG, SORIANO MA, MONN JA,SCHOEPP DD, LODGE D, MCCULLOCH J: Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia. NeuroscL Lett. (1998) 254:121–123.
  • BOND A, RAGUMOORTHY N, MONN JA et al: LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia. NeuroscL Lett. (1999) 273:191–194.
  • KINGSTON AE, O'NEILL MJ, LAM A, BALES KR, MONN JA, SCHOEPP DD: Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795. Eur: Pharmacol (1999) 377:155–165.
  • BRUNO V, BATTAGLIA G, CASABONA G, COPANI A, CACIAGLI F, NICOLETTI F: Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. NeuroscL (1998) 18:9594–9600.
  • BOND A, JONES NM, HICKS CA et Neuroprotective effects of LY379268, a selective mG1u2/3 receptor agonist: investigations into possible mechanism of action in vivo. Pharmacol Exp. The]: (2000) 294:800–809.
  • JACKSON PF, SLUSHER BS: Design of naaladase inhibitors: a novel neuroprotective strategy. Curr: Med. Chem. (2001) 8:949–957.
  • SLUSHER BS, VORNOV JJ, THOMAS AG et al: Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. (1999) 5:1396–1402.
  • LU XM, TANG Z, LIU W, LIN Q, SLUSHER BS: N-acetylaspartylglutamate protects against transient focal cerebral ischemia in rats. Eur: Pharmacol (2000) 408:233–239.
  • DE COLLE C, BESSIS AS, BOCKAERT J, ACHER F, PIN JP: Pharmacological characterization of the rat metabotropic glutamate receptor type 8a revealed strong similarities and slight differences with the type 4a receptor. Eur: Pharmacol. (2000) 394:17–26.
  • GERLAI R, RODER JC, HAMPSON DR: Altered spatial learning and memory in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. Behav. Neurosci. (1998) 112:525–532.
  • LI H, OHISHI H, KINOSHITA A, SHIGEMOTO R, NOMURA S, MIZUNO N: Localization of a metabotropic glutamate receptor, mGluR7, in axon terminals of presumed nociceptive, primary afferent fibers in the superficial layers of the spinal dorsal horn: an electron microscope study in the rat. Neurosci. Lett. (1997) 223:153–156.
  • ACHER FC, TELLIER FJ, AZERAD R, BRABET IN, FAGNI L, PIN JP: Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.J. Med. Chem. (1997) 40:3119–3129.
  • AMORI L, COSTANTINO G, MARINOZZI M et al.: Synthesis, molecular modeling and preliminary biological evaluation of 1-amino-3-phosphono-3-cyclopentene- 1-carboxylic acid and 1-amino-3-phosphono-2-cyclopentene-1-carboxylic acid, two novel agonists of metabotropic glutamate receptors of group III. Bioorg. Med. Chem. Lett. (2000) 10:1447–1450.
  • TOMS NJ, JANE DE, KEMP MC, BEDINGFIELD JS, ROBERTS PJ: The effects of (RS)-alpha cyclopropy1-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist. Br. J. PharmacoL 119: 851–854.
  • GASPARINI F, INDERBITZIN W, FRANCOTTE E et al: (+)-4-phosphonophenylglycine (PPG) a new group III selective metabotropic glutamate receptor agonist. Bioorg. Med. Chem. Lett. (2000) 10:1241–1244.
  • THOMAS NK, WRIGHT RA, HOWSON PA, KINGSTON AE, SCHOEPP DD, JANE DE: (S)-3,4-DCPG, a potent and selective mG1u8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology (2001) 40:311–318.
  • BRUNO V, COPANI A, BONANNO L et al.: Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures. Ear: Pharmacol (1996) 310:61–66.
  • BRUNO V, BATTAGLIA G, KSIAZEK I et al: Selective activation of mG1u4 metabotropic glutamate receptors is protective against excitotoxic neuronal death. " Neurosci. (2000) 20:6413–6420.
  • SABELHAUS CF, SCHRODER UH, BREDER J, HENRICH-NOACK P, REYMANN KG: Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R, 5)-4-phosphonophenylglycine. Br. J. PharmacoL (2000) 131:655–658.
  • BHAVE G, KARIM F, CARLTON SM, GEREAU RW, 4th: Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat. Neurosci. (2001) 4:417–423.
  • KARIM F, WANG CC, GEREAU RW, 4th: Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J. Neurosci. (2001) 21:3771–3779.
  • FUNDYTUS ME, YASHPAL K, CHABOT JG et al: Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats. Br: J. Pharmacol (2001) 132:354–367.
  • WALKER K, BOWES M, PANESAR M et al: Metabotropic glutamate receptor subtype 5 (mG1u5) and nociceptive function. I. Selective blockade of mG1u5 receptors in models of acute, persistent and chronic pain. Neuropharmacology (2001) 40:1–9.
  • WALKER K, REEVE A, BOWES M et mG1u5 receptors and nociceptive function II. mG1u5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology (2001) 40:10–19.
  • BORDI F, UGOLINI A: Involvement of mGluR(5) on acute nociceptive transmission. Brain Res. (2000) 871:223–233.
  • HELTON DR, TIZZANO JP, MONN JA, SCHOEPP DD, KALLMAN MJ: Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. " Pharmacol Exp. Ther. (1998) 284: 651–660.
  • MOGHADDAM B, ADAMS BW: Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science (1998) 281:1349–1352.
  • WONG CG, SCHERER SW, SNEAD OC 3, HAMPSON DR: Localization of the human mGluR4 gene within an epilepsy susceptibility locus (1). Brain Res. MoL Brain Res. (2001) 87:109–116.
  • LIE AA, BECKER A, BEHLE K et al: Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerability. Ann. Neural. (2000) 47:26–35.
  • MOLDRICH RX, TALEBI A, BEART PM, CHAPMAN AG, MELDRUM BS: The mG1u(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti-and proconvulsant in DBA/2 mice. Neurosci. Lett. (2001) 299:125–129.
  • YIP PK, MELDRUM BS, RATTRAY M: Elevated levels of group-III metabotropic glutamate receptors in the inferior colliculus of genetically epilepsy-prone rats following intracollicular administration of L-serine-0-phosphate. J. Neurochem. (2001) 78:13–23.

Websites

  • www.strokecenter.org A web resource for information about stroke care and research.
  • www.stroke.org National stroke association.
  • www.strokecenter.orgitrials Stroke trials directory.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.